One way to make health care more personalized is to use a person's DNA sequence or genome to predict their risk of disease. But as the field of precision medicine grows, so have concerns that we may be leaving a large fraction of Americans out.
CAST's goal is to move beyond learning about the genetics of human diseases that currently comes from datasets of predominantly white, European people.